Quantbot Technologies LP Sells 27,516 Shares of Trupanion, Inc. $TRUP

Quantbot Technologies LP decreased its stake in Trupanion, Inc. (NASDAQ:TRUPFree Report) by 83.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,410 shares of the financial services provider’s stock after selling 27,516 shares during the period. Quantbot Technologies LP’s holdings in Trupanion were worth $234,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in TRUP. Voya Investment Management LLC boosted its holdings in Trupanion by 2.4% in the third quarter. Voya Investment Management LLC now owns 10,379 shares of the financial services provider’s stock valued at $449,000 after acquiring an additional 243 shares during the last quarter. Bank of Montreal Can raised its holdings in Trupanion by 3.5% during the 2nd quarter. Bank of Montreal Can now owns 7,280 shares of the financial services provider’s stock worth $403,000 after purchasing an additional 245 shares during the last quarter. Thrivent Financial for Lutherans lifted its position in shares of Trupanion by 1.1% in the 2nd quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider’s stock worth $1,376,000 after purchasing an additional 282 shares during the period. EP Wealth Advisors LLC lifted its position in shares of Trupanion by 2.9% in the 2nd quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider’s stock worth $571,000 after purchasing an additional 292 shares during the period. Finally, New York State Common Retirement Fund boosted its stake in shares of Trupanion by 0.4% in the 2nd quarter. New York State Common Retirement Fund now owns 83,930 shares of the financial services provider’s stock valued at $4,646,000 after purchasing an additional 296 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on TRUP. Stifel Nicolaus lowered their target price on shares of Trupanion from $38.00 to $35.00 and set a “hold” rating for the company in a research note on Friday, February 13th. Cantor Fitzgerald cut their price target on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 14th. Weiss Ratings lowered Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 4th. Wall Street Zen downgraded Trupanion from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Finally, Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Two investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $45.50.

Get Our Latest Stock Report on TRUP

Insider Activity at Trupanion

In related news, CFO Fawwad Qureshi sold 4,645 shares of the company’s stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $25.61, for a total transaction of $118,958.45. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO John R. Gallagher sold 5,283 shares of the stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $26.52, for a total value of $140,105.16. Following the completion of the transaction, the chief operating officer owned 32,387 shares in the company, valued at approximately $858,903.24. The trade was a 14.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 31,107 shares of company stock worth $949,347 over the last quarter. Company insiders own 5.42% of the company’s stock.

Trupanion Stock Up 2.1%

Trupanion stock opened at $25.70 on Thursday. The company has a market capitalization of $1.12 billion, a PE ratio of 57.11 and a beta of 1.62. Trupanion, Inc. has a 12-month low of $24.53 and a 12-month high of $57.88. The firm’s fifty day moving average is $31.23 and its 200 day moving average is $37.40. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.27.

Trupanion (NASDAQ:TRUPGet Free Report) last posted its quarterly earnings results on Thursday, February 12th. The financial services provider reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01). Trupanion had a return on equity of 5.39% and a net margin of 1.35%.The company had revenue of $376.85 million during the quarter, compared to analyst estimates of $375.89 million. During the same quarter in the previous year, the business posted $0.04 earnings per share. The company’s revenue for the quarter was up 11.7% compared to the same quarter last year. As a group, sell-side analysts predict that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

About Trupanion

(Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

Read More

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.